MH-associated diseases: who really needs a non-triggering technique?

Malignant hyperthermia (MH) is a pharmacogenetic clinical syndrome that occurs in patients with preexisting abnormal skeletal muscle. It manifests clinically as a hypermetabolic crisis when a MH-susceptible individual is exposed to an inhalational anesthetic or a depolarizing muscle relaxant (ie, succinylcholine).